Avicenna Biosciences
Avicenna Biosciences is a startup headquartered in Durham, United States, founded in 2020. It has raised at least $12.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Avicenna Biosciences has raised at least $12.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Avicenna Biosciences sits inside the Durham region R&D ecosystem in the Global R&D Labs Directory.
Other startups in Durham
- Atsena Therapeutics
- Elo Life Systems
- Extellis
- Geo Land Solutions
- Grefort Electrical
- Growth Curve Bio
- GTM Buddy
- IOTA Software
- MIH
- Opine Market
- Plant Path
Related
- Innovation profile of Durham
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Avicenna Biosciences do?
Avicenna Biosciences is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Avicenna Biosciences raised?
At least $12.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Avicenna Biosciences based?
Avicenna Biosciences is headquartered in Durham, United States.
When was Avicenna Biosciences founded?
Avicenna Biosciences was founded in 2020.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.